ConvaTec Group PLC (CNVVY)
13.40
+0.15
(+1.11%)
USD |
OTCM |
May 17, 15:45
ConvaTec Group Total Assets (Quarterly): 3.714B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.714B |
| June 30, 2023 | 3.753B |
| December 31, 2022 | 3.592B |
| June 30, 2022 | 3.686B |
| December 31, 2021 | 3.674B |
| June 30, 2021 | 3.743B |
| December 31, 2020 | 3.766B |
| June 30, 2020 | 3.578B |
| Date | Value |
|---|---|
| December 31, 2019 | 3.610B |
| June 30, 2019 | 3.727B |
| December 31, 2018 | 3.660B |
| June 30, 2018 | 3.799B |
| December 31, 2017 | 3.801B |
| June 30, 2017 | 3.656B |
| December 31, 2016 | 3.514B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.578B
Minimum
Jun 2020
3.766B
Maximum
Dec 2020
3.684B
Average
3.700B
Median
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.021B |
| Shareholders Equity (Quarterly) | 1.693B |
| Debt to Equity Ratio | 0.7248 |
| Current Ratio | 1.622 |
| Net Debt Paydown Yield | 0.63% |